MDS and Covid-19: MaPPs System with MAR and Reminder Charts for widespread use available now

Posted on 31st March 2020 by Lisa Yates

As a credible Health Information System supplier to the NHS, we at Mistura Informatics Ltd, (registered prescribers, clinical pharmacists and medics) have just made the MaPPs system free to access for 3 months to help our colleagues, particularly where pharmacy services are unable to cope with compliance aids.

System Description:

MaPPs: Medicines - A Patient Profile Summary is a fully indemnified web-based medicines management system, composed of three parts, to provide support for patients and improve adherence and medicines taking behaviour. [Health Service Journal (HSJ )Award Finalist: Improving Care WIth Technology, 2017]

Medicines Information Monographs: that allows a profile summary of all a patient’s medication to be compiled in electronic format which can be emailed and printed as leaflets to take home and/or stored for uploading to the clinical record. Each monograph of medicines information provides a hard copy summary of what a healthcare professional would say to a patient in plain English including the main uses, side effects & ones to get worried about (rare but important) and warning or cautions including any monitoring required.

Medicines Adherence Toolkit: to support medicines taking including:

1.     Medicines Reminder Charts (MRC)

2.     Medicines Administration Charts (MARs)

Medicines Easy Read Leaflets (MERLS): provide summary information as pictograms and brief phrases for people with a Learning Disability, children and older people with cognitive challenges. MERLs is also useful for where English is not the first language.

Please contact the team direct for more information and to sign up for your free trial via the link below:

New Fact Sheet added for Clozapine and Coronavirus

Posted on 25th March 2020 by Lisa Yates

Brand new fact sheets were added to the Choice and Medication downloadable leaflet suite on 23rd March 2020 for Clozapine and Coronavirus (COVID-19), which was recently authored by Professor Stephen Bazire.

Choice and Mediation have taken the lead and added both a UK and Australian fact sheet on the implications of COVID-19 for people taking clozapine with information and facts relating to various aspects e.g. supplies, blood tests, and precautions, etc. A New Zealand version can be added as soon as it is appropriate should the situation deteriorate.

The new leaflet is linked directly from the clozapine page on your subscribing trusts portal and a link can also be found on the handy fact sheets page. Should you require any further information or would like to subscribe to Choice and Medication for either personal use, a professional subscription or need an organisational license for your trust please contact the team via the link below:

NHS England’s National Mental Health Director calls for loot box ban

Posted on 10th March 2020 by Zac Mavin

Loot boxes have been seen as a controversial aspect of the games industry. There have been calls to class loot boxes as a form of gambling including from the UK’s Department for Digital, Culture, Media & Sport Committee. Belgium has banned loot boxes in games and both Australia and the United States are investigating the impact of loot boxes and if they should be considered a form of gambling.

To read the full article click the link below: